191 related articles for article (PubMed ID: 9366423)
21. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
Mohan K; Moulin P; Stevenson MM
J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426
[TBL] [Abstract][Full Text] [Related]
22. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
Nagler A; Lanier LL; Phillips JH
J Immunol; 1988 Oct; 141(7):2349-51. PubMed ID: 3262658
[TBL] [Abstract][Full Text] [Related]
23. Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.
Li H; Cao MY; Lee Y; Lee V; Feng N; Benatar T; Jin H; Wang M; Der S; Wright JA; Young AH
Cancer Immunol Immunother; 2005 Nov; 54(11):1115-26. PubMed ID: 15891881
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells.
Warren HS; Kinnear BF; Kastelein RL; Lanier LL
J Immunol; 1996 May; 156(9):3254-9. PubMed ID: 8617947
[TBL] [Abstract][Full Text] [Related]
25. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury.
Aronson FR; Libby P; Brandon EP; Janicka MW; Mier JW
J Immunol; 1988 Jul; 141(1):158-63. PubMed ID: 3259966
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
27. Ultrastructural and functional effects of lipopolysaccharide and interleukin-2 on human NK cells.
Kang YH; Carl M; Watson LP
Scanning Microsc; 1988 Sep; 2(3):1567-86. PubMed ID: 3059478
[TBL] [Abstract][Full Text] [Related]
28. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
Iho S; Yamamoto T; Takahashi T; Yamamoto S
J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
[TBL] [Abstract][Full Text] [Related]
29. Role of serotonin in the regulation of human natural killer cell cytotoxicity.
Hellstrand K; Hermodsson S
J Immunol; 1987 Aug; 139(3):869-75. PubMed ID: 2439597
[TBL] [Abstract][Full Text] [Related]
30. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
Lebow LT; Jewett A; Bonavida B
J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130
[TBL] [Abstract][Full Text] [Related]
31. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
[TBL] [Abstract][Full Text] [Related]
32. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
34. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells.
Chen CP; Boyadjieva NI; Advis JP; Sarkar DK
Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358
[TBL] [Abstract][Full Text] [Related]
35. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells.
Jewett A; Bonavida B
J Immunol; 1996 Feb; 156(3):907-15. PubMed ID: 8558016
[TBL] [Abstract][Full Text] [Related]
36. Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2.
Lee SH; Yun S; Piao ZH; Jeong M; Kim DO; Jung H; Lee J; Kim MJ; Kim MS; Chung JW; Kim TD; Yoon SR; Greenberg PD; Choi I
J Immunol; 2010 Jul; 185(2):917-28. PubMed ID: 20543098
[TBL] [Abstract][Full Text] [Related]
37. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
38. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
39. Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells.
Furukawa M; Yasukawa M; Yakushijin Y; Fujita S
J Immunol; 1994 Jun; 152(12):5768-75. PubMed ID: 7911490
[TBL] [Abstract][Full Text] [Related]
40. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
